Clinical Trial

Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial\] is to study the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during painful procedures for patients with hematological malignancies The main question\[s\] it aims to answer are: Does VR effectively reduce pain during painful procedures for patients with hematological malignancies ? Does VR effectively reduce anxiety during painful procedures for patients with hematological malignancies ? Interventional group (intra-group comparaison): This design allows each patient to act as his own control.: The intervention consists of a complete sequence involving three phases: Period 1 (standard care), a washout period of at least seven days, and Period 2 (VR session). External control group (inter-group comparaison): Patients will be assigned to the intervention group first, and then a matching external control patient will be selected based on age and type of procedure.
Trial Details
NCT Number NCT07085065
Lead Sponsor Yesmine Amara
Collaborators: University of Sfax
Conditions Pain Management, Anxiety, Procedures, Hematological Neoplasms
Enrollment 365 participants
Start Date 2024-02-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-25